Skip to main content
Recall Canary
Niacin Extended-release Tablets 1,000 mg
← Back to all recalls
DRUG RECALLMODERATE

Niacin Extended-release Tablets 1,000 mg

Lannett is recalling Niacin Extended-release Tablets 1,000 mg due to failed dissolution specifications.

What to do

Contact your healthcare provider or pharmacist if you have questions or concerns regarding your medication. Do not stop taking your medication without consulting a medical professional.

Recalled
Listed
Updated
Recall No.
D-0584-2026
Agency
FDA
Firm
Lannett Company Inc.
Recall ID
99107
Status
ONGOING

Recall at a glance

Quantity recalled
3984 bottles

Why it was recalled

Lannett is recalling specific lots of Niacin Extended-release Tablets due to failed dissolution specifications. The product failed to meet stability testing requirements for dissolution at the 24-hour timepoint.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Niacin Extended-release Tablets, USP, 1

Lot code
25282724A, 2027
Strength
000 mg
NDC / UPC
NDC 62175-322-46

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other recent recalls from Lannett Company Inc.

All recalls from Lannett Company Inc.

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification